Anna Lembke
Stanford University School of Medicine
Anna Lembke is a Professor of Psychiatry at the Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Her work centers on addiction medicine, psychiatry, and dopamine-related behaviors, and she is the author of 'Dopamine Nation: Finding Balance in the Age of Indulgence'. Her published research focuses on substance use disorders, examining treatments for opioid and alcohol dependence, associated cardiovascular risks, and the use of machine learning and social media data to monitor addiction trends.
40 claims checked on air: 3 context 1 contradicted 2 overstated 29 supported 5 unverified 3 flagged
What they said on air - flagged
Addiction leads to disconnection or severing of large neuronal pathways between deep limbic structures (like the nucleus accumbens and ventral tegmental area) and the prefrontal cortex.
"What we're finding is that there's actually a disconnect. So there are large neuronal circuits and pathways between those deep limbic structures and the prefrontal cortex that literally get severed or disconnected when people become addicted." (said at 0:11:41)
Substance use disorders and addiction are widely documented to involve altered functional connectivity and reduced white matter microstructural integrity within frontostriatal and corticolimbic circuits connecting the prefrontal cortex to deep structures such as the nucleus accumbens. However, claiming that these neuronal pathways "literally get severed" exaggerates the nature of these neurobiological changes. The pathways remain anatomically present; addiction is characterized by changes in synaptic plasticity, functional coupling, and microstructural metrics (such as reduced fractional anisotropy on diffusion tensor imaging), rather than literal physical transection or severing of nerve tracts.
- partial: Emerging role for the medial prefrontal cortex in alcohol-seeking behaviors. (Addictive behaviors 2018) · cited 62x in the literature
"The medial prefrontal cortex (mPFC) plays an important role in high-order executive processes and sends highly organized projections to sub-cortical regions controlling mood, motivation and impulsivity." (abstract, introduction, passage verified)
pubmedfull study (doi) - partial: Brain tract structure predicts relapse to stimulant drug use. (Proceedings of the National Academy of Sciences of the United States of America 2022) · cited 25x in the literature
"reduced diffusion metrics of a tract projecting from the right anterior insula to the NAcc were associated with subsequent relapse to stimulant use, but not with previous diagnosis." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Nucleus accumbens: a systematic review of neural circuitry and clinical studies in healthy… (Journal of neurosurgery 2023) · cited 39x in the literature
"The NAcc and its corticolimbic connections to other brain regions, such as the prefrontal cortex, are largely involved in reward and pain processes, with distinct functional circuitry between the shell and core in healthy patients." (abstract, results, passage verified)
pubmedfull study (doi)
Human studies demonstrate that dopamine levels gradually rise during the latter half of exercise and remain elevated for hours afterwards before returning to baseline without entering a dopamine deficit state.
"And there are studies in humans showing that when humans expose themselves to exercise, for example, dopamine levels gradually rise over the latter half of the exercise, and then when the exercise stops, dopamine levels will remain elevated for hours afterwards before going back down to the baseline level position without ever going into that dopamine deficit state." (said at 1:02:04)
While human neuroimaging studies using positron emission tomography (PET) with tracers like [11C]raclopride demonstrate that acute exercise stimulates endogenous dopamine release in the human brain, they do not show the continuous kinetic profile described by the speaker. PET provides static snapshots of receptor binding displacement across discrete scan conditions rather than continuous dynamic tracking across the phases of an exercise session. The specific temporal kinetics claimed—gradual elevation during the latter half of exertion and sustained elevation for hours post-exercise without entering a deficit state—derive from invasive intracerebral microdialysis studies in rodents, not in humans.
Women are substantially more vulnerable to love addiction or pathological relationship dependency than men.
"Women, however, are much more vulnerable to love addiction, which is also real, right? The pathological, compulsive falling in love with partners and then getting into these relationships that are really dramatic and not healthy" (said at 1:57:15)
The claim that women are substantially or "much more vulnerable" to love addiction compared to men is not supported by psychiatric and empirical literature. "Love addiction" is not an officially recognized diagnosis in the DSM-5 or ICD-11, and systematic reviews highlight an absence of standardized epidemiological data. Furthermore, recent empirical studies evaluating psychological vulnerability models (such as impulsivity, psychological distress, and emotion dysregulation) for love addiction show structural invariance across genders, and meta-analytic evidence indicates that associations with key drivers like anxious attachment are not uniquely higher in women (and can be stronger in male-predominant samples).
- contradicts: Is love passion an addictive disorder? (The American journal of drug and alcohol abuse 2010) · cited 140x in the literature
"There are no recognized definitions or diagnostic criteria for "love addiction"... There are no data on the epidemiology, genetics, co-morbidity, or treatment of love addiction." (abstract, results)
pubmedfull study (doi) - contradicts: Problematic Love Behaviors and Correlated Factors: A Systematic Review with Subgroup Meta-… (Archives of sexual behavior 2026) · cited 1x in the literature
"Conversely, the link between LA and anxious attachment was stronger in samples with a higher proportion of men." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Psychological Distress, Motor Impulsivity and Love Addiction: The Mediating Role of Emotio… (Psychological reports 2026)
"multigroup analysis confirmed that the structural model was strictly invariant across genders." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications
- Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matching.European heart journal. Quality of care & clinical outcomes 2026 · CEBM Level 3
- A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients.Alcohol and alcoholism (Oxford, Oxfordshire) 2026 · CEBM Level 3
- The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial.BMJ open 2026 · CEBM Level 5
- TikTok is a valuable data source for tracking the opioid crisis.NPJ digital medicine 2026 · CEBM Level 4
- Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study.Journal of addiction medicine 2025 · CEBM Level 3
- Which social media platforms facilitate monitoring the opioid crisis?PLOS digital health 2025 · CEBM Level 4
- Monitoring the opioid epidemic via social media discussions.NPJ digital medicine 2025 · CEBM Level 4
- Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features.Journal of the American Medical Informatics Association : JAMIA 2025 · CEBM Level 3
- Experiences With Substance Use Disorder Treatment and the Role of Social Norms in the Asian American Pacific Islander Community: A Qualitative Study.Journal of addiction medicine 2025 · CEBM Level 5
- Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribing.Journal of addictive diseases 2024 · CEBM Level 5
- Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022.Addiction (Abingdon, England) 2024 · CEBM Level 4
- Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.Addiction (Abingdon, England) 2024 · CEBM Level 3
- Which social media platforms facilitate monitoring the opioid crisis?medRxiv : the preprint server for health sciences 2024 · CEBM Level 4
- The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness.Health affairs scholar 2024 · CEBM Level 5
- A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission rates.Journal of addictive diseases 2023 · CEBM Level 4
- Predicting premature discontinuation of medication for opioid use disorder from electronic medical records.AMIA ... Annual Symposium proceedings. AMIA Symposium 2023 · CEBM Level 3
- Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.Lancet (London, England) 2022 · CEBM Level 5
- Buprenorphine Microdosing Cross Tapers: A Time for Change.International journal of environmental research and public health 2022 · CEBM Level 5
- Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report.Journal of addictive diseases 2021 · CEBM Level 4
- A systematic review of stigma interventions for providers who treat patients with substance use disorders.Journal of substance abuse treatment 2021 · CEBM Level 1
- Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity Pain.Journal of general internal medicine 2020 · CEBM Level 3
- Tapering Long-Term Opioid Therapy.American family physician 2020 · CEBM Level 5
- Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence.Annals of internal medicine 2020 · CEBM Level 5
- Online mutual-help intervention for reducing heavy alcohol use.Journal of addictive diseases 2020 · CEBM Level 4
- Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020).Journal of studies on alcohol and drugs 2020 · CEBM Level 5
- Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.Pain medicine (Malden, Mass.) 2019 · CEBM Level 5
- Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.JAMA internal medicine 2019 · CEBM Level 5
- Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.Annals of internal medicine 2019 · CEBM Level 5
- Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine.American journal of therapeutics 2019 · CEBM Level 4
- Substance Use Among Older Adults: Ethical Issues.Focus (American Psychiatric Publishing) 2019 · CEBM Level 5
- Our Other Prescription Drug Problem.The New England journal of medicine 2018 · CEBM Level 5
- The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2018 · CEBM Level 5
- Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2018 · CEBM Level 4
- Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.Anesthesiology clinics 2018 · CEBM Level 5
- Extended treatment for cigarette smoking cessation: a randomized control trial.Addiction (Abingdon, England) 2017 · CEBM Level 2
- Tapering Patients Off of Benzodiazepines.American family physician 2017 · CEBM Level 5
- A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research.Tobacco control 2016 · CEBM Level 5
- Distribution of Opioids by Different Types of Medicare Prescribers.JAMA internal medicine 2016 · CEBM Level 3
- Assessment of provider attitudes toward #naloxone on Twitter.Substance abuse 2016 · CEBM Level 4
- Weighing the Risks and Benefits of Chronic Opioid Therapy.American family physician 2016 · CEBM Level 5
- Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence.BMJ open 2016 · CEBM Level 4
- Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.Journal of substance abuse treatment 2016 · CEBM Level 4
- Use of Opioid Agonist Therapy for Medicare Patients in 2013.JAMA psychiatry 2016 · CEBM Level 4
- A qualitative study of treatment-seeking heroin users in contemporary China.Addiction science & clinical practice 2015 · CEBM Level 4
- Recovery-oriented policy and care systems in the UK and USA.Drug and alcohol review 2014 · CEBM Level 5
- Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.Journal of psychiatric research 2014 · CEBM Level 4
- Clinical management of alcohol use disorders in the neurology clinic.Handbook of clinical neurology 2014 · CEBM Level 5
- The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.Psychoneuroendocrinology 2013 · CEBM Level 3
- Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression.Psychiatry research 2013 · CEBM Level 4
- Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.Psychological services 2013 · CEBM Level 4
- Why doctors prescribe opioids to known opioid abusers.The New England journal of medicine 2013 · CEBM Level 5
- From self-medication to intoxication: time for a paradigm shift.Addiction (Abingdon, England) 2013 · CEBM Level 5
- Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.Addiction science & clinical practice 2013 · CEBM Level 3
- Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians.Minnesota medicine 2013 · CEBM Level 5
- The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression.Psychiatry research 2012 · CEBM Level 4
- Time to abandon the self-medication hypothesis in patients with psychiatric disorders.The American journal of drug and alcohol abuse 2012 · CEBM Level 5
- Risk of future trauma based on alcohol screening scores: a two-year prospective cohort study among US veterans.Addiction science & clinical practice 2012 · CEBM Level 3
- Why doctors prescribe opioids to known opioid abusers.The New England journal of medicine 2012 · CEBM Level 5
- Alcohol screening scores and the risk of new-onset gastrointestinal illness or related hospitalization.Journal of general internal medicine 2011 · CEBM Level 3
- Depression and smoking cessation: does the evidence support psychiatric practice?Neuropsychiatric disease and treatment 2007 · CEBM Level 5
- Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.Psychiatric services (Washington, D.C.) 2006 · CEBM Level 3
- Update on augmentation of antidepressant response in resistant depression.Current psychiatry reports 2005 · CEBM Level 5
- A prospective trial of modafinil as an adjunctive treatment of major depression.Journal of clinical psychopharmacology 2004 · CEBM Level 4
- Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices.Clinical EEG and neuroscience 2004 · CEBM Level 5
- Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.Journal of psychiatric practice 2004 · CEBM Level 4
- Why is this special issue on women's professional development in psychiatry necessary?Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2004 · CEBM Level 5
- Safety of antidepressants in the elderly.Expert opinion on drug safety 2003 · CEBM Level 5
- A Friday in the life of an academic psychiatrist.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2003 · CEBM Level 5
- A Day in the Life of an Academic Psychiatrist.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2003 · CEBM Level 5
- Impaired recognition of facial emotion in mania.The American journal of psychiatry 2002 · CEBM Level 4
- Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.Bipolar disorders 2002 · CEBM Level 4